Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.
Identifieur interne : 009462 ( Ncbi/Merge ); précédent : 009461; suivant : 009463Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.
Auteurs : Hoda E. Sayegh [États-Unis] ; Maria S. Asdourian [États-Unis] ; Meyha N. Swaroop [États-Unis] ; Cheryl L. Brunelle [États-Unis] ; Melissa N. Skolny [États-Unis] ; Laura Salama [États-Unis] ; Alphonse G. Taghian [États-Unis]Source :
- Current breast cancer reports [ 1943-4588 ] ; 2017.
Abstract
Breast cancer-related lymphedema (BCRL) is a chronic, adverse, and much feared complication of breast cancer treatment, which affects approximately 20% of patients following breast cancer treatment. BCRL has a tremendous impact on breast cancer survivors, including physical impairments and significant psychological consequences. The intent of this review is to discuss recent studies and analyses regarding the risk factors, diagnosis, prevention through early screening and intervention, and management of BCRL.
DOI: 10.1007/s12609-017-0237-8
PubMed: 28894513
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000006
- to stream PubMed, to step Curation: 000006
- to stream PubMed, to step Checkpoint: 000006
Links to Exploration step
pubmed:28894513Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.</title><author><name sortKey="Sayegh, Hoda E" sort="Sayegh, Hoda E" uniqKey="Sayegh H" first="Hoda E" last="Sayegh">Hoda E. Sayegh</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Asdourian, Maria S" sort="Asdourian, Maria S" uniqKey="Asdourian M" first="Maria S" last="Asdourian">Maria S. Asdourian</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Swaroop, Meyha N" sort="Swaroop, Meyha N" uniqKey="Swaroop M" first="Meyha N" last="Swaroop">Meyha N. Swaroop</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Brunelle, Cheryl L" sort="Brunelle, Cheryl L" uniqKey="Brunelle C" first="Cheryl L" last="Brunelle">Cheryl L. Brunelle</name><affiliation wicri:level="2"><nlm:affiliation>Department of Physical Therapy, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Physical Therapy, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Skolny, Melissa N" sort="Skolny, Melissa N" uniqKey="Skolny M" first="Melissa N" last="Skolny">Melissa N. Skolny</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Salama, Laura" sort="Salama, Laura" uniqKey="Salama L" first="Laura" last="Salama">Laura Salama</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28894513</idno><idno type="pmid">28894513</idno><idno type="doi">10.1007/s12609-017-0237-8</idno><idno type="wicri:Area/PubMed/Corpus">000006</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000006</idno><idno type="wicri:Area/PubMed/Curation">000006</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000006</idno><idno type="wicri:Area/PubMed/Checkpoint">000006</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000006</idno><idno type="wicri:Area/Ncbi/Merge">009462</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.</title><author><name sortKey="Sayegh, Hoda E" sort="Sayegh, Hoda E" uniqKey="Sayegh H" first="Hoda E" last="Sayegh">Hoda E. Sayegh</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Asdourian, Maria S" sort="Asdourian, Maria S" uniqKey="Asdourian M" first="Maria S" last="Asdourian">Maria S. Asdourian</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Swaroop, Meyha N" sort="Swaroop, Meyha N" uniqKey="Swaroop M" first="Meyha N" last="Swaroop">Meyha N. Swaroop</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Brunelle, Cheryl L" sort="Brunelle, Cheryl L" uniqKey="Brunelle C" first="Cheryl L" last="Brunelle">Cheryl L. Brunelle</name><affiliation wicri:level="2"><nlm:affiliation>Department of Physical Therapy, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Physical Therapy, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Skolny, Melissa N" sort="Skolny, Melissa N" uniqKey="Skolny M" first="Melissa N" last="Skolny">Melissa N. Skolny</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Salama, Laura" sort="Salama, Laura" uniqKey="Salama L" first="Laura" last="Salama">Laura Salama</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name><affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><series><title level="j">Current breast cancer reports</title><idno type="ISSN">1943-4588</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Breast cancer-related lymphedema (BCRL) is a chronic, adverse, and much feared complication of breast cancer treatment, which affects approximately 20% of patients following breast cancer treatment. BCRL has a tremendous impact on breast cancer survivors, including physical impairments and significant psychological consequences. The intent of this review is to discuss recent studies and analyses regarding the risk factors, diagnosis, prevention through early screening and intervention, and management of BCRL.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28894513</PMID><DateCreated><Year>2017</Year><Month>09</Month><Day>12</Day></DateCreated><DateRevised><Year>2017</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1943-4588</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Current breast cancer reports</Title><ISOAbbreviation>Curr Breast Cancer Rep</ISOAbbreviation></Journal><ArticleTitle>Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.</ArticleTitle><Pagination><MedlinePgn>111-121</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12609-017-0237-8</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Breast cancer-related lymphedema (BCRL) is a chronic, adverse, and much feared complication of breast cancer treatment, which affects approximately 20% of patients following breast cancer treatment. BCRL has a tremendous impact on breast cancer survivors, including physical impairments and significant psychological consequences. The intent of this review is to discuss recent studies and analyses regarding the risk factors, diagnosis, prevention through early screening and intervention, and management of BCRL.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Highly-evidenced risk factors for BCRL include axillary lymph node dissection, lack of reconstruction, radiation to the lymph nodes, high BMI at diagnosis, weight fluctuations during and after treatment, subclinical edema within and beyond 3 months after surgery, and cellulitis in the at-risk arm. Avoidance of potential risk factors can serve as a method of prevention. Through establishing a screening program by which breast cancer patients are measured pre-operatively and at follow-ups, are objectively assessed through a weight-adjusted analysis, and are clinically assessed for signs and symptoms, BCRL can be tracked accurately and treated effectively. Management of BCRL is done by a trained professional, with research mounting towards the use of compression bandaging as a first line intervention against BCRL. Finally, exercise is safe for breast cancer patients with and without BCRL and does not incite or exacerbate symptoms of BCRL.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Recent research has shed light on BCRL risk factors, diagnosis, prevention, and management. We hope that education on these aspects of BCRL will promote an informed, consistent approach and encourage additional research in this field to improve patient outcomes and quality of life in breast cancer survivors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sayegh</LastName><ForeName>Hoda E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asdourian</LastName><ForeName>Maria S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swaroop</LastName><ForeName>Meyha N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunelle</LastName><ForeName>Cheryl L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skolny</LastName><ForeName>Melissa N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salama</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taghian</LastName><ForeName>Alphonse G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Breast Cancer Rep</MedlineTA><NlmUniqueID>101498096</NlmUniqueID><ISSNLinking>1943-4588</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer-related lymphedema</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Management</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Survivorship</Keyword></KeywordList><CoiStatement>Conflict of Interest Hoda Sayegh, Maria Asdourian, Meyha Swaroop, Cheryl Brunelle, Melissa Skolny, and Laura Salama declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28894513</ArticleId><ArticleId IdType="doi">10.1007/s12609-017-0237-8</ArticleId><ArticleId IdType="pmc">PMC5590641</ArticleId></ArticleIdList><pmc-dir>nihms</pmc-dir>
</PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Sayegh, Hoda E" sort="Sayegh, Hoda E" uniqKey="Sayegh H" first="Hoda E" last="Sayegh">Hoda E. Sayegh</name></region><name sortKey="Asdourian, Maria S" sort="Asdourian, Maria S" uniqKey="Asdourian M" first="Maria S" last="Asdourian">Maria S. Asdourian</name><name sortKey="Brunelle, Cheryl L" sort="Brunelle, Cheryl L" uniqKey="Brunelle C" first="Cheryl L" last="Brunelle">Cheryl L. Brunelle</name><name sortKey="Salama, Laura" sort="Salama, Laura" uniqKey="Salama L" first="Laura" last="Salama">Laura Salama</name><name sortKey="Skolny, Melissa N" sort="Skolny, Melissa N" uniqKey="Skolny M" first="Melissa N" last="Skolny">Melissa N. Skolny</name><name sortKey="Swaroop, Meyha N" sort="Swaroop, Meyha N" uniqKey="Swaroop M" first="Meyha N" last="Swaroop">Meyha N. Swaroop</name><name sortKey="Taghian, Alphonse G" sort="Taghian, Alphonse G" uniqKey="Taghian A" first="Alphonse G" last="Taghian">Alphonse G. Taghian</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009462 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 009462 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28894513
|texte= Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28894513" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |